Inventor
Daniel Fortin
Inventor
Québec, CA
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
C07KPeptides33%
C07DHeterocyclic compounds17%
PatentTitleYear
8,557,765'Spatially-defined macrocycles incorporating peptide bond surrogates'20138,080,555'Purine derivatives and their use for treatment of autoimmune diseases'20118,022,252'Spatially-defined macrocyclic compounds useful for drug discovery'20117,683,061'Triazine dimers for the treatment of autoimmune diseases'20107,550,431'Spatially-defined macrocycles incorporating peptide bond surrogates'20097,452,862'Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2013Patents assigned to TRANZYME PHARMA INC (4)· patent assignee history
2008Based in Montreal, CA· patent location history
2009–2013Based in Québec, CA· patent location history
2010–2011Patents assigned to PROMETIC BIOSCIENCES INC (2)· patent assignee history
2010–2011Based in Rosemère, CA· patent location history
2011–2013Patents assigned to FORTIN DANIEL (2)· patent assignee history
2013Patents assigned to BEAUBIEN SYLVIE (1)· patent assignee history
2013Patents assigned to DESLONGCHAMPS PIERRE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TRANZYME PHARMA INC | 4 | 2008–2013 |
| FORTIN DANIELself | 2 | 2011–2013 |
| PROMETIC BIOSCIENCES INC | 2 | 2010–2011 |
| BEAUBIEN SYLVIE | 1 | 2013 |
| DESLONGCHAMPS PIERRE | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Québec, CA | 3 | 2009–2013 |
| Rosemère, CA | 2 | 2010–2011 |
| Montreal, CA | 1 | 2008 |